Similar articles

• Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.

  Soto J, Hernandez N, Mejia H, Grogl M, Berman J. Soto J, et al. Clin Infect Dis. 1995 Jan;20(1):47-51. doi: 10.1093/clinids/20.1.47. Clin Infect Dis. 1995. PMID: 7727669 Clinical Trial.
• Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.

  Soto J, Fuya P, Herrera R, Berman J. Soto J, et al. Clin Infect Dis. 1998 Jan;26(1):56-8. doi: 10.1086/516267. Clin Infect Dis. 1998. PMID: 9455509 Clinical Trial.
• [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].

  Schallreuter KU, Lemke KR. Schallreuter KU, et al. Hautarzt. 1994 Nov;45(11):783-6. doi: 10.1007/s001050050172. Hautarzt. 1994. PMID: 7822205 German.
• [Cutaneous leishmaniasis].

  Enk CD, Gardlo K, Hochberg M, Ingber A, Ruzicka T. Enk CD, et al. Hautarzt. 2003 Jun;54(6):506-12. doi: 10.1007/s00105-003-0530-5. Epub 2003 Apr 18. Hautarzt. 2003. PMID: 12759734 Review. German.
• [Treatment of localized cutaneous leishmaniasis].

  Buffet P, Caumes E, Gentilini M. Buffet P, et al. Ann Dermatol Venereol. 1994;121(6-7):503-11. Ann Dermatol Venereol. 1994. PMID: 7702288 Review. French. No abstract available.